Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Post by FredTheVoiceon May 28, 2019 9:44am

156 Views

Post# 29777576

Buyers are here

It took a long year,

But it seems that the last week of trading is showing that buyers are here, and gaining momentum on the shorts and sellers.

Thats the reason that the extension news from EUROPE didn't drive the price down again.

If Tanguay is right, than we have a week left of waiting to here TH/THERF strategy on NASH.

And maybe NASDAQ will be announced a couple days following that news.

FTV.

Bullboard Posts

Investors eye Australian gold mining projects amid promising developments